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Abstract
Background: High-throughput sequencing technologies offer new perspectives for biomedical, agronomical and 
evolutionary research. Promising progresses now concern the application of these technologies to large-scale studies 
of genetic variation. Such studies require the genotyping of high numbers of samples. This is theoretically possible 
using 454 pyrosequencing, which generates billions of base pairs of sequence data. However several challenges arise: 
first in the attribution of each read produced to its original sample, and second, in bioinformatic analyses to distinguish 
true from artifactual sequence variation. This pilot study proposes a new application for the 454 GS FLX platform, 
allowing the individual genotyping of thousands of samples in one run. A probabilistic model has been developed to 
demonstrate the reliability of this method.
Results: DNA amplicons from 1,710 rodent samples were individually barcoded using a combination of tags located in 
forward and reverse primers. Amplicons consisted in 222 bp fragments corresponding to DRB exon 2, a highly 
polymorphic gene in mammals. A total of 221,789 reads were obtained, of which 153,349 were finally assigned to 
original samples. Rules based on a probabilistic model and a four-step procedure, were developed to validate 
sequences and provide a confidence level for each genotype. The method gave promising results, with the 
genotyping of DRB exon 2 sequences for 1,407 samples from 24 different rodent species and the sequencing of 392 
variants in one half of a 454 run. Using replicates, we estimated that the reproducibility of genotyping reached 95%.
Conclusions: This new approach is a promising alternative to classical methods involving electrophoresis-based 
techniques for variant separation and cloning-sequencing for sequence determination. The 454 system is less costly 
and time consuming and may enhance the reliability of genotypes obtained when high numbers of samples are 
studied. It opens up new perspectives for the study of evolutionary and functional genetics of highly polymorphic 
genes like major histocompatibility complex genes in vertebrates or loci regulating self-compatibility in plants. 
Important applications in biomedical research will include the detection of individual variation in disease susceptibility. 
Similarly, agronomy will benefit from this approach, through the study of genes implicated in productivity or disease 
susceptibility traits.
Background
Highly polymorphic genes constitute a major component
of the functional genetics of biota. They are involved in
many crucial functions including the regulation of self
incompatibility in plants [1,2], fungi [3] and marine inver-
tebrates [4], immunity in vertebrates [5,6] or insects [7],
sex-determination in insects [8,9] and disease resistance
in plants [10]. By definition, such genes display a very
high number of alleles/variants within a single population
or a single species, and many individuals are heterozy-
gous for these genes. For instance, exon 2 of the MHC
class II gene DRB has 878 variants in humans and dis-
plays an excess of heterozygotes within populations
IMGT/HLA database,[11]. Another feature is their mode
of evolution, promoting interspecific polymorphism
MHC, [12]. This makes them particularly interesting in
the study of community genetics e.g. [13,14]. Further-
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more, the potential involvement of highly polymorphic
genes in inter-specific interactions outcomes may pro-
mote the emergence/persistence of biodiversity through
speciation or diversifying selection processes [14-17].
Despite their important roles in genetics and evolution,
in the context of medicine or agronomy, highly polymor-
phic genes are seldom studied within population and
community genetics. In non-model organisms, one major
limitation is the difficulty of genotyping high numbers of
individuals. Highly polymorphic genes are, by definition,
prone to display numerous, extremely diverse variants as
well as many heterozygotes within populations, which
can hardly be genotyped using direct sequencing. The
direct sequencing of amplicons would often result in the
superposition of two very different sequences, giving
mostly unreadable electropherograms. Sequencing must
therefore be preceded by the separation of the two copies
(for diploids) of the gene. For the classical Sanger
method, a previous step of cloning is necessary, which is
expensive and time consuming. Alternative methods rely
on the indirect characterisation of sequence variability
and involve capillary electrophoresis single-strand con-
formation polymorphism (CE-SSCP), denaturing gradi-
ent gel electrophoresis (DGGE), high resolution melting
curve analysis (HRMCA), PCR using sequence-specific
primers (PCR-SSP), oligonucleotide chips or other
related techniques see e.g. [18-23]. However, these indi-
rect methods are not fully informative because of the
non-negligible rates of homoplasy, i.e. preventing differ-
ent variants from being distinguished based on sequence
conformation e.g. [24]. Moreover, they do not provide the
nucleotide sequences, thus precluding many analyses in
evolutionary and functional genetics. Cloning the target
sequences into bacteria and sequencing different clones
using the Sanger approach, so as to recover the different
variants, may be required to further analyze relationships
between migration patterns and sequences e.g. [25]. Such
approaches are expensive and time consuming and
require many clones to be sequenced for each sample in
order to guarantee a high probability of including all vari-
ants e.g. [26]. Cloning-sequencing is often unaffordable
for population and community studies, which require
several hundreds of individuals to be genotyped.
Over the last five years, the development of high-
throughput genomic sequencing technologies has
opened up new and exciting perspectives in evolutionary
studies, biomedicine and agronomy [27]. The 454 GS
FLX (Roche) platform, for instance, allows the reading of
100 bp- to 500 bp-fragments. Unlike the classical Sanger
method, the 454 technology includes an emulsion
polymerisation chain reaction (emPCR) before the
pyrosequencing step [28]. This stage allows the isolation
of each DNA strand before sequencing, just as in the
cloning-sequencing approach. This feature is of particu-
lar interest in the characterization of genetic variability of
single highly polymorphic and multi-copy genes, for
which many very different variants may co-occur within
individuals. The main limitation of the 454 methods
remains the high cost of each run (between 7,000 and
20,000 euros). This cost is, however, compensated by the
high number of reads produced in one run [> 1 million
reads (see Table 1 for definition), [29]]. It is thus theoreti-
cally possible to genotype a high number of individuals.
Such large-scale pyrosequencing of genes has been
applied to detect SNPs and small deletions and inser-
tions: for example those potentially involved in hereditary
diseases and cancers [30]. However, the genetic variation
observed in the mentioned study was not reattributed to
o r i g i n a l  s a m p l e s .  L a r g e - s c a l e  p y r o s e q u e n c i n g  i s  t h u s  a
promising approach, provided that each read produced
may be reliably attributed to its original sample. In this
way, Babik et al. [31] have applied the 454 technology to
genotype 96 individuals at the MHC class II DRB gene.
Different solutions have been proposed recently to allow
a posteriori attribution of the sequences produced. One
straightforward way to recover the original sample of a
given sequence is to use nucleotide barcodes. They con-
sist in short nucleotide sequences called 'tags' fixed at the
extremity of DNA strands. These tags must produce a
unique barcode for each sample. Those are either ligated
to DNA fragments to be sequenced [32], or are included
directly in the 5' end of the primers for sequencing ampli-
cons (i.e. tagged-primer in [33]). For both approaches, the
number of different tags to be synthesized is equal to the
n u m b e r  o f  s a m p l e s  t o  b e  g e n o t y p e d .  B y  c o n t r a s t ,  t h e
m e t h o d  d e s i g n e d  b y  B i e r n e  et al. [34] for cloning-
sequencing studies is based on the combination of tags in
Table 1: Definition of the terms used.
Term used Definition
Reads Sequences passing quality control 
(QC) criteria after BaseCall, 
generated from 454 sequencing 
using manufacturer specifications.
Sequences Reads remaining in the dataset after 
the first step of our data processing 
procedure (Table 2).
Variants Sequences differing by at least one 
base pair substitution or by an 
indel.
Artifactual sequences 
or artifactual variants
Sequences or variants that resulted 
from sequencing errors, 
polymerase errors and non-specific 
amplifications of paralogue and 
pseudogene during PCR (Table 2).
True sequences or true 
variants
Sequences or variants that were 
retained after validation at all 
stages of our stepwise procedure.Galan et al. BMC Genomics 2010, 11:296
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the forward and reverse primers. Only n sets of primers
are thus required for the coding of n2  samples. This
approach has recently been applied to 454 sequencing
system [35].
Here we describe a 454 approach that shows similari-
ties with the one developed by Babik et al. [31], but that is
optimized for the analysis of thousands of individuals in a
single region of a 454 plate. Using one half of a 454 run,
we were able to barcode PCR amplicons from 1710 sam-
ples of rodents, corresponding to 24 species. We used
combinations of tagged primers, for a nuclear gene that is
known to be highly polymorphic in mammals, the MHC
class II DRB gene for a review see [36]. Amplicons were
multiplexed for the emPCR to produce a high number of
reads in a single run. The tagged primers also allowed a
posteriori attribution of most reads to their sample of ori-
gin. We then proposed a stepwise procedure for data
analysis and variant validation. Sequences containing
errors have previously been shown to occur in some
reads during 454 sequencing [37]. Those needed to be
distinguished from correct sequences. We developed a
probabilistic model to provide a confidence level for each
g e n o t y p e  o b s e rv e d .  T h i s  m o d e l  w i l l  a l s o  b e  u s e f u l  f o r
optimizing the number of samples to be multiplexed in
one 454 run.
Methods
Samples and DNA extractions
The experiment was based on 1710 rodent tissue samples
(either toes or lungs) collected between 2001 and 2008 in
Europe, Southeast Asia and Caribbean islands. These
samples corresponded to 1614 individual rodents belong-
ing to 24 different species and 11 genera. Reproducibility
of the genotyping was estimated for 96 samples that had
been randomly chosen from the dataset and processed
twice for the entire procedure.
DNA was extracted from the 1710 samples using 18
plates of the DNeasy Tissue Kit (Qiagen) following the
manufacturer's recommendations. Various steps of the
experiment were carried out using rigorous laboratory
protocols to prevent contamination by alien DNA and
amplicons. PCR plates were prepared in a DNA-free
room and under a sterile hood. We systematically used
filter tips for the different steps of DNA extraction and
PCR. The absence of contamination was checked at this
stage and along the whole laboratory procedure using
three negative controls per extraction plate. They corre-
sponded to one extraction blank (extraction without sam-
ple tissue), one PCR blank (a tube with PCR mix without
DNA) and one aerosol blank (a PCR blank with the cap
open during the whole manipulation).
The total DNA set was then divided into two sets of 855
DNA samples, referred to as Pool A and Pool B. These
pools were independently analyzed using the same com-
bination of barcodes. This allowed the relative efficiency
of the different barcodes to be determined.
Tagged primer design, PCRs and sequencing
We used the target-specific primers developed by Schad
et al. [38] to analyze exon 2 of the DRB gene in rodents.
These primers are JS1 (Forward 5'-GAGTGTCATTTC-
TACAACGGGACG-3') and JS2 (Reverse 5'-GATCCCG-
TAGTTGTGTYTGCA-3'). They amplify a 171 bp
fragment (excluding primers) of exon 2 from the DRB
gene in several mammal species [38]. One or several cop-
ies can be amplified with this set of primers depending on
the rodent species considered (e.g. a single copy in Apo-
demus sp. [39], duplicated copies in Gerbillurus paeba
[40] and M. glareolus [41]). There was no prior knowl-
edge on DRB variability and duplication for all species
studied except M. glareolus and  Apodemus sp. in our
experiment. These primers were modified by adding a
short 3 bp sequence (the tag) and 19 bp adaptors to the 5'
ends of JS1 ('A': 5'-GCCTCCCTCGCGCCATCAG-3') and
JS2 ('B': 5'-GCCTTGCCAGCCCGCTCAG-3'). These
adaptors were required for the emPCR and 454 pyrose-
quencing (see Figure 1). The key sequence TCAG at the 3'
ends of both adaptors A and B, which were used during
the BaseCall step as a quality control (QC) measure to
validate the reads. Primers were synthesized by Eurogen-
tec and purified using the standard selective precipitation
optimized process (SePOP).
We designed 36 different tags for the forward primers,
and 24 different tags for the reverse primers (see details
in Figure 1). This leads to 864 potential unique combina-
tions of forward and reverse tags. Samples were individu-
ally barcoded during the preparation of the PCR plates.
Thirty-six forward primers were dispensed into the plates
'vertically', so that each row contained a different forward
primer, while the 26 reverse primers were dispensed 'hor-
izontally', with wells in each column containing a differ-
ent reverse primer (Figure 1). Thus, each well harboured
a single, unique 6-bp barcode through the combination of
forward and reverse tags.
PCRs were carried out in a 25 μL reaction volumes con-
taining 2 mM MgCl2, 100 μM dNTPs, 0.1 μM of each
primer and 0.75 U AmpliTaq Gold® (Applied Biosystems)
in the appropriate 1× PCR Buffer II and de-ionized DNA-
and RNA-free water. DNA samples were added to this
reaction mix in a separate room to avoid DNA contami-
nation. DNA (1.5 μL, i.e. nearly 40 ng) was added to each
well. The PCR was optimized through touchdown proto-
col. Samples were subjected to initial denaturation at
95°C for 15 min, followed by 10 cycles of denaturation at
94°C for 30 s, annealing with touchdown at 65°C to 55°C
(-1°C/cycle) for 30 s and extension at 72°C for 30 s, fol-
lowed by 30 cycles of denaturation at 94°C for 30 s,
annealing at 55°C for 30 s and extension at 72°C for 30 s,Galan et al. BMC Genomics 2010, 11:296
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Figure 1 Design of the barcoding system. 36 forward and 24 reverse tags were dispensed into nine 96-well plates producing 864 unique combi-
nations of 6-nucleotide sequences named barcodes. 1: reverse tags forming a homopolymer GG with the "key" sequence. 2: reverse tags that could 
not be recovered because of homopolymer formation (see text for more details).
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CGA CGC CGT CTA CTC CTG GAC GAG GAT GCA GCG GCT
GAG GAG GAG GAG GAG GAG GAG GAG GAG GAG GAG GAG
CGA CGC CGT CTA CTC CTG GAC GAG GAT GCA GCG GCT
GAT GAT GAT GAT GAT GAT GAT GAT GAT GAT GAT GAT
CGA CGC CGT CTA CTC CTG GAC GAG GAT GCA GCG GCT
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CGA CGC CGT CTA CTC CTG GAC GAG GAT GCA GCG GCT
GCG GCG GCG GCG GCG GCG GCG GCG GCG GCG GCG GCG
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GTC GTC GTC GTC GTC GTC GTC GTC GTC GTC GT
C
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CGA CGC CGT CTA CTC CTG GAC GAG GAT GCA GCG GCT
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with a final extension phase at 72°C for 10 min. PCR
products (5 μL) were checked on a 1.5% agarose gel. The
remaining PCR products were sent to Cogenics™ Genome
Express where pyrosequencing was carried out using a
454 GS FLX System (Roche Diagnostics GmbH/454 Life
Sciences Corporation).
All PCR products were analyzed using the LabCHIP® 90
system and DNA CHIP 5 K from Caliper Life Science.
This microfluidic electrophoresis allows fragment size
and individual amplicon concentration, excluding primer
and dNTP residues, to be determined. As described
above, two equimolar pools (Pool A and Pool B) of ampli-
cons were produced. To eliminate unspecific products,
the two pools were run on an agarose gel and purified by
gel excision of fragments of 260 bp ± 12 bp. The quality of
the pools were checked by size range analysis using a
DNA 1000 Assay on the 2100 Bioanalyzer (Agilent Tech-
nologies) and quantified by fluorescent measurement
using the Quant-it™ Picogreen® DNA assay (Invitrogen).
The emPCR, corresponding to clonal amplification of
the purified amplicon pool, was carried out using the GS
emPCR Kit II (Roche Diagnostics GmbH). Briefly, ampli-
cons were immobilized onto DNA capture beads. The
amplicon-beads obtained were added to a mixture of
amplification mix and oil and vigorously shaken on a Tis-
sue Lyser (Qiagen) to create "micro-reactors" containing
both amplification mix and a single bead. Emulsion was
dispensed into a 96-well plate and the PCR amplification
program was run according to the manufacturer's recom-
mendations. Following amplification, the emulsion was
chemically broken and the beads carrying the amplified
DNA library were recovered and washed by filtration.
Positive beads were purified using the biotinylated primer
A (complementary to adaptor A), which binds to strepta-
vidin-coated magnetic beads. The DNA library beads
were then separated from the magnetic beads by melting
the double-stranded amplification products, leaving a
population of bead-bound single-stranded template DNA
fragments. The sequencing primer was then annealed to
the amplified single-stranded DNA. Lastly, beads carry-
ing amplified single-stranded DNA were counted with a
Z2™ Cell Counter (Beckman Coulter).
Pools A and B were simultaneously processed in one
GS FLX run using one half of a 70 × 75 mm Pico-Titer
plate device (Roche Diagnostics GmbH) and one GS LR-
70 sequencing kit (Roche Diagnostics GmbH). Briefly, the
70 × 75 mm Pico-Titer plate was divided in four sections
(one corresponding to Pool A, one to Pool B and two to
another pyrosequencing project) using the Medium
Regions Bead Loading Gasket (Roche Diagnostics
GmbH). According to the manufacturer's recommenda-
tions for amplicon sequencing, 250,000 DNA beads were
loaded for each pool mixed with an appropriate volume
of packing beads and enzyme beads. After the Pre-Wash
run, the sequencing run was started with the "Full Analy-
sis for Amplicon" parameter set.
Bioinformatics and data processing
A non-negligible number of errors are generated during
PCR [42] and pyrosequencing [37]. Non-specific amplifi-
cation may also occur. We thus developed a stepwise data
processing procedure aimed at detecting and discarding
most of the reads that exhibit sequencing errors or that
correspond to genes other than the targeted gene (see
objectives and rationales, Table 2). This procedure relied
on three assumptions. First, reads with errors were
expected to appear at lower frequencies than reads with-
out errors in the whole dataset and for each individual
sample. This assumption was validated using a probabi-
listic approach. Considering the probability of substitu-
tion errors, the probability of artifactual variants (that
arose from substitution errors) occurring in our dataset
was ≈ 0.11, and the probability of observing three times
the same artifactual variant is very low, p1 ≈ 10-8 (Addi-
tional Information [see Additional file 1]). Second, reads
exhibiting indels with lengths that are not multiples of
three base pairs were considered as artifacts because they
would induce shifts in the reading frame. Third, the reli-
ability of the genotype obtained for a given individual
s a m p l e  s h o u l d  d e p e n d s  m a i n l y  o n  t h e  n u m b e r  o f
sequences obtained for this sample and on the number of
copies of the gene in the species studied.
Our validation procedure involved four consecutive
steps (Table 2). Briefly, the first cleaning step allowed
removal of most imperfect reads from the dataset (reads
with incomplete primers or barcodes, reads correspond-
ing to sequences that were observed only once in the
entire dataset and reads exhibiting indels of sizes that
were not multiples of three base pairs). The next two
steps were based on thresholds under which the number
or frequency of sequences obtained per sample was insuf-
ficient to provide reliable genotypes. Rationales and pro-
cedures for establishing these thresholds are described
below. The last step involved the alignment of remaining
sequences using Mega 4.0 [43]. This step allowed the
detection and elimination of sequences that corre-
sponded to pseudogenes, paralogs and recombinant chi-
meric sequences originating from a mixture of sequences
of two different variants e.g. for chimeric sequences pro-
duced during PCR see [42]. Paralogs and pseudogenes
were then identified using nucleotide blast against all
sequencing data available in Genbank (default parame-
ters).
Basic statistics and genetic diversity
We calculated simple statistics for the whole dataset and
independently for pools A and B. Statistical parameters
took into account the total number of reads (R), the totalGalan et al. BMC Genomics 2010, 11:296
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number of sequences (N), the total number of variants
(A) and the number of sequences obtained for each vari-
ant j (Nj). These same statistical principles were applied
for each individual sample i  as the total number of
sequences (Ni), the number of variants (Ai), the number
of sequences for each variant j (Nij) and the frequency of
each variant (Fij), corresponding to Nij/Ni.
Thresholds for genotype and variant validation
We then determined a confidence level for each geno-
type. The rationales for this was that (i) a minimal num-
ber of sequences are required for reliable genotyping; and
(ii) true variants must be sequenced several times within
the same sample in order to be validated and distin-
guished from artifactual variants (Table 1). We first
defined the threshold T1, corresponding to the minimal
number of sequences required per individual to deter-
mine its complete genotype, with a low probability of
missing variants. We computed the probability of ampli-
fying at least r times all the variants of the gene studied
for a given sample. This probability was based on n, the
total number of true sequences obtained for the sample,
and  m, the maximal number of variants for the gene
within a sample. The value m depends on the number of
gene copies and on the degree of ploïdy of the studied
organism. For instance, m  = 2 for a single copy of a
nuclear gene within a diploid genome, and m = 4 for a
duplicated nuclear gene within a diploid genome, or for a
single-copy nuclear gene in a tetraploïd genome, and so
on. A program is now freely available on the web http://
www.lirmm.fr/~caraux/Bioinformatics/NegativeMulti-
nomial/ to calculate the probability f(r,m,n) of having at
least r  sequences of each of the m variants potentially
observed within the n sequences of a given sample. Here,
we considered and discussed different values for r (1, 3, 5
and 10) and for m (2, 4, 6 and 8).
We then defined a second threshold, T2, to eliminate
artifactual variants that arose from substitution errors.
Based on our initial assumptions and in accordance with
the results of our probabilistic calculations (Additional
Table 2: Objectives and rationales for each step of the data processing procedure to validate variants and genotypes.
Steps Objectives Rationales
1 Remove reads with incomplete barcode information. Reads cannot be assigned to any individual.
Remove reads that display imperfect match with the primers. An imperfect match with primers may cause a shift in the 
reading frame and/or errors in the barcode.
Remove sequences that are unique within the pool. Unique sequences probably result from sequencing errors (first 
assumption). This step reduced the dataset and then facilitated 
subsequent data analyses. Note that this step may be relaxed 
for small datasets (unique sequences will also be removed 
during Step 3).
Remove reads that display indels that are not multiples of 
three base pairs.
Such indels probably result from sequencing errors (second 
assumption). Note that this step may be relaxed when focusing 
on non-functional genes.
2 Remove samples with a low number of sequences. A low number of sequences may induce an incomplete 
genotyping (second assumption).
The minimum number of sequences required to obtain a 
reliable genotype is estimated taking into account the number 
of copies amplified for the gene studied (threshold 1).
3 Remove variants with a low number of sequences for a given 
sample.
Variants represented only rarely within samples probably result 
from sequencing errors (first assumption).
The minimum number of sequences required to validate a 
given variants of an individual genotype is estimated from the 
distribution of variant frequencies for the given sample 
(threshold 2).
4 Remove variants that do not correspond to the gene studied, 
using sequence alignment.
Some inconsistencies may still exist in the dataset such as 
recombinant chimeric sequences originating from a mixture of 
the sequences of two different alleles, [42], pseudogenes or 
paralogs, which can occur at high frequencies within individual 
samples.
See text for the definitions of assumptions and thresholds.Galan et al. BMC Genomics 2010, 11:296
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Information [see Additional file 1]), artifactual variants
should occur at much lower frequencies than true vari-
ants. We therefore analyzed the distribution of variant
frequencies calculated individually for each sample (Fij,
see above). We expected multinomial-shaped distribu-
tions with one peak at very low frequency values corre-
sponding to artifactual variants and several peaks at
medium-high frequency values corresponding to true
variants. These peaks should include a very high fre-
quency peak (about 90-100%), corresponding to homozy-
gous samples, and one or more peaks of medium
frequency values (30 to 50%), corresponding to heterozy-
gous samples. Ideally, the threshold value T2 should be
chosen to discard most of the artifactual variants and
none (or very few) of the true variants.
Validation and efficiency of the method
We analyzed the efficiency of barcoding by comparing
the number of sequences obtained for each tag between
pools A and B. We used a one way ANOVA with the
number of sequences as an independent variable, and the
reverse tag, the forward tag and the pool as dependent
qualitative variables. All two-way interactions were tested
and removed when not significant. This analysis was per-
formed on the dataset obtained after the first step of the
data processing. The number of sequences was log-trans-
formed to normalize its distribution. Post-hoc pairwise
comparisons were performed with the Tukey-Kramer
method. We then compared the genotypes obtained for
the 96 replicated samples to investigate the reproducibil-
ity of the genotyping. Finally, we examined the distribu-
tion of the frequency of true and artifactual variants
within samples (Fij). All analyses were performed using
GENSTAT 7.1 (Lawes Agricultural Trust, Rothamstead).
Results
None of the 54 blanks were found to be positive after
PCR amplification. We obtained 221,789 quality control
(QC) reads overall (R), with RA = 91,467 for pool A and RB
= 130,322 for pool B. This difference between pools was
probably attributed to the difference in DNA concentra-
tion between pool purifications, which was 0.83 and 1.84
ng/μL for pools A and B, respectively.
Data processing
Step 1
The first step was the detection and suppression of most
of the imperfect reads (Table 2). We had some difficulties
in determining sequence using reverse tags starting with
base G. These tags formed a homopolymer GG with the
"key" sequence (e.g. 5'-TCAG-GNN-3'). In this case it
appears that the G of the tag was removed altogether with
the key sequence during the data processing with the GS-
FLX Data Analysis Software, creating a shift of one base
in tag and sequence reading. This problem was encoun-
tered for eight reverse tags (see Figure 1). We performed
an ad hoc analysis, focusing on the two last bases of the
tags, allowing sequence information to be recovered for
six of the eight tags. After the elimination of imperfect
reads, the number of sequences per variant displayed an
L-shaped distribution (Figure S1 [see Additional file 2]).
The number of reads that could be assigned to variants in
each pool were 63,841 and 89,508, corresponding to
10,420 and 9,427 variants, in pools A and B, respectively.
We found 7,686 variants (74%) and 5,985 variants (64%)
to occur only once in datasets A and B, respectively. The
minimum and maximum numbers of sequences assigned
per variant were 1 and 2,513 sequence(s) per variant in
pool A, and 1 and 12,688 in pool B. Variants occurring
only once and variants containing indels were then
removed from both datasets. This considerably reduced
the datasets and facilitated further bioinformatic manip-
ulations.
At the end of the first step, we had NA = 53,661 and NB =
81,627 sequences, corresponding to AA = 2,322 and AB =
2,833 variants for pools A and B, respectively. Altogether,
about 33% of the reads were eliminated in the first step.
Over the 855 samples studied in each pool, we succeeded
in assigning sequences for 745 of them in pool A and 764
in pool B. The number of sequences obtained for each
sample strongly depended on the sample considered (Fig-
ure S2 [see Additional file 2]). Averages of sequences per
sample were respectively NAi = 65.6 (min. = 0, max. = 207)
and NBi = 82.7 (min. = 0, max. = 297) for pools A and B.
Overall we did not obtain any sequence for 201 samples.
This was explained for 54 samples by low amplicon con-
centrations observed before pooling (< 1 ng/μl) and prob-
ably resulting from poor DNA conservation. For the 144
other samples, the reverse tag sequence could not be
recovered because of the formation of a homopolymer
with the sequencing key (see above).
Step 2
The aim of the second step was to provide a confidence
level for each genotype produced. We estimated the
probability of amplifying at least r times all the different
variants of the gene studied for a given sample. This prob-
ability depended on n, the total number of true sequences
obtained for the sample, and m, the maximal number of
variants for the gene within a sample (see the Materials
and Methods section). We then plotted the probability
f(r,m,n) against the number of sequences n for different
values of r and m (Figure S3 [see Additional file 2]). As
expected, we observed that for a given probability, n must
be increased when r and m values increase. That means
that to achieve a given confidence level, more sequences
per sample (n) are required when the number of copies
amplified of the gene under study (m) increases, or whenGalan et al. BMC Genomics 2010, 11:296
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the number of sequences required for validating an vari-
ant as true (r) increases. To further analyze our results,
we fixed the r-value to three. This value was based on sta-
tistical considerations. Actually, we showed that the
probability of observing three times the same artifactual
sequence was very low, p1 ≈ 10-8 (see Additional Informa-
tion [Additional file 1]). Moreover it also corresponded to
the standard procedure in MHC gene studies where three
independent observations of the same sequence are rec-
ommended to validate a variant that has been identified
through a cloning-sequencing approach see [44]. Further-
more, our approach allows choosing any other value of r
and x, depending on particular characteristics (e.g. num-
ber of samples and number of sequences for each sample)
in other experiments.
The threshold T1 (i.e. the minimal number of sequences
required for reliable genotyping) was then calculated for r
= 3, giving a confidence level of 10-3 (Figure 2). Simula-
tions showed the threshold value T1 ranged from T1 = 19
for a single copy gene in diploid species to T1 = 104 for an
octaploid species, or for a quadruplicated gene in a dip-
loid species. In a similar way, T1 = 46 for a single copy
gene in tetraploid species or for a duplicated gene in a
diploid species. Samples with a number of sequences n
<T1 were then removed from the dataset, as their geno-
types were not considered to be reliable. At this stage, 75
samples were removed from the dataset, corresponding
to 5% of the samples.
Step 3
The third step involved separating true from artifactual
variants within each sample, based on the frequency of
variants within samples (Fij). We plotted the distribution
of Fij after grouping data based either on the number of
copies of the DRB gene (Figure 3) or on taxonomy (Figure
S4 [see Additional file 3]). All distributions obtained dis-
played the expected multimodal shape, with three peaks
corresponding to frequencies of 1-4%, 30-60% and 80-
100%. A few exceptions were detected, however. Maxo-
mys, in which the DRB gene is quadruplicated, showed no
variants in the 80-100% range, consistent with the
absence of homozygotes. By contrast, Niviventer showed
a low occurrence of variants in the 30-60% range, associ-
a t e d  w i t h  a  h i g h  o c c u r r e n c e  o f  h o m o z y g o t e s .  F o r  t h e
other species, we fixed the threshold T2 value to 4%. All
variants with Fij <T2 in a given sample i were removed
from the sample i, being considered as artifactual within
the particular sample. By the end of this step, 48,294
sequences, corresponding to 600 variants, were con-
served for pool A and 68,413 sequences, corresponding
to 354 variants, were conserved for pool B. This step
allowed the mean number of variants per sample to be
reduced from 12 to 2.5, suggesting that most of the arti-
factual variants had been removed from the dataset.
Step 4
The sequences of the remaining variants were aligned
separately for each sample, and analyzed by eye (Figure
S5 for illustration [see Additional file 3]). We detected
pseudogenes that were orthologous to the RT1-Hb gene
of the laboratory rat Rattus norvegicus. We also found
variants that were orthologous to the DQB gene, a para-
log of the DRB gene, belonging to the same MHC class II
multigenic family. Recombinant chimeric sequences were
quite common in the dataset, occurring at high frequen-
cies (up to 10%) in some samples. They were easily
detected in alignments because their sequences origi-
nated from a mixture of the sequences of two different,
true variants occurring in the same sample. After remov-
ing those non-specific variants from the data set, the
number of sequences became lower than T1 (see Step 2)
for 27 samples. Those samples were then eliminated, as
their genotypes were not considered to be reliable.
At the end of our data processing procedure, 1407 sam-
ples were reliably genotyped (following our criteria) over
the 1710 initially processed (201 samples removed at Step
1, 75 at Step 2 and 27 at Step 4). Moreover, 45,038
sequences and 251 variants had been retained in pool A,
as where 65,836 sequences and 147 variants in pool B.
Overall, 392 different variants were characterized and
sequenced, with an average of 277 sequences per variant
(min: 5; max: 12,688). Of the 392 variants finally validated
by our data processing for exon 2 of the DRB gene, 36 had
been previously reported in GenBank (Myodes: 15; Arvi-
cola: 12; Apodemus: 8; Rattus: 1).
Barcode bias
The ANOVA conducted on the numbers of sequences
remaining after step 1 (i.e. after removing tags affected by
the homopolymer problem) was significant (F112,1394 =
2.857, P < 10-4). The interaction between the two factors,
"forward tags" and "reverse tags", could not be statistically
tested in the ANOVA. The analysis showed significant
differences between pools (P = 3 × 10-4) and between for-
ward tags (P < 10-4). The use of forward tags CAC and
CGC resulted in lower numbers of sequences, whereas
TCA, TCT and TGT led to higher numbers of sequences
(Figure S6 [see Additional file 2]). Interactions between
pools and tags were significant and showed that differ-
ences between tags were not consistent between pools
(Forward tags, P = 6 × 10-3; Reverse tags, P < 10-4). The
lower numbers of sequences obtained for the forward
tags CAC and CGC were only significant in pool B.
Among reverse tags, GCT was associated with the lowest
number of sequences in pool A, whereas CAC had the
lowest number of sequences of all the other tags in poolGalan et al. BMC Genomics 2010, 11:296
http://www.biomedcentral.com/1471-2164/11/296
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B. Thus, despite finding some significant differences, no
systematic bias could be related to tag sequences.
Genotype reliability
Among the 96 replicated samples, only 66 were success-
fully genotyped twice by the end of our bioinformatics
procedure. Unfortunately, the 30 other samples could not
be genotyped twice due to the formation of homopoly-
mers by particular tags (see above). Of these 66 samples,
63 displayed the same genotype in both replicates. The
three samples showing non-identical genotypes were
heterozygous for one replicate and homozygous (with a
drop in one of the two variants) for the other. In one case,
the 'missing' variant had been amplified, but its frequency
within the sample (2%) was lower than the T2 threshold
value (4%). Overall, the reproducibility of our genotyping
was 95%.
Further analysis allowed the examination of 12,022
sequences, corresponding to 953 variants. True variants
accounted for 84 ± 8% (mean ± S.E.%) of the sequences
p r o d u c e d  w i t h i n  s a m p l e s ,  s u b s t i t u t i o n s  ( 1  o r  2  b p )
accounted for 6 ± 5%, insertions (1 or 2 bp) for 2 ± 3%,
deletions (1 or 2 bp) for 4 ± 9%, chimeras for 6 ± 7% and
other genes (pseudogenes and paralogs) for 1 ± 2%.
Efficiency of the method
We were able to genotype 1,407 rodent samples from 24
different species at a confidence level of 10-3. Maxomys
and Niviventer genera showed the lowest genotyping suc-
cess rate (18% and 56%, respectively; Table 3). The qua-
druplication of the DRB  gene in Maxomys  (up to 7
variants were observed in some individuals) may account
for most of the difficulties in genotyping these animals.
However, Niviventer seemed to have a high occurrence of
null alleles, with many individuals producing only a small
number of sequences, and most other individuals being
homozygotes (Table 3). The genotyping success rate was
fairly high, generally above 90%, for all other species.
Figure 2 Confidence level of genotyping. f is the probability of amplifying, at least three times, all the different variants of the gene studied for a 
given sample. This probability depends on n, the total number of sequences per sample, and m, the maximal number of variants for the gene within 
a sample. T1 is the threshold value that corresponds to the minimal number of sequences required per individual to determine a complete genotype, 
with a 10-3 probability of missing a variant.Galan et al. BMC Genomics 2010, 11:296
http://www.biomedcentral.com/1471-2164/11/296
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Discussion
Recent development of high-throughput genomic
sequencing, considerably reducing the costs of sequenc-
ing, has opened up new perspectives for modern biology
[45]. Here, we report a new laboratory procedure allow-
ing the multiplexing and sequencing of one or several
PCR amplicons for hundreds of samples in only one 454
run, allowing most of the reads generated to be attributed
to their samples of origin. Data processing procedure and
probabilistic model were developed for the validation of
new variants and the estimation of confidence levels for
each genotype produced. These procedures gave promis-
ing results, resulting in the successful genotyping of 1407
rodent samples from 24 different species, and the
sequencing of 392 different variants of the DRB  gene
(exon 2) in only one half of a standard 454 picotiter plate.
Replicates confirmed the high reproducibility (over 95%)
of this genotyping method.
Comparison with other methods
The method described here is particularly suitable for the
determination of genotypes and sequences for highly
variable and potentially multiplicated genes. For example,
the high level of variant diversity observed for exon 2 of
the DRB gene in Myodes glareolus (71 variants) prevents
the use of classical methods like SSCP and DGGE. These
methods are based on differences in migratory patterns
during electrophoresis. As they do not directly provide
information on the variant sequences, they are subject to
homoplasy (i.e. the same pattern for different variants),
thus preventing complete resolution for variants exhibit-
ing a similar conformation or related sequences e.g. [46].
Nevertheless, these methods are useful for datasets con-
taining a restricted set of variant forms e.g. in endangered
species, [47,48]. They may be inadequate, however, for
use in population genomics/genetics, involving large
datasets of thousands of individuals. Indeed, in this study,
it is unlikely that as many as 392 variants, or even the 71
variants identified for the bank vole Myodes glareolus,
would have been distinguishable on the basis of their
migratory patterns. Alternatives such as PCR-SSP, which
is based on amplification using primers that are specific
to a group of variants, were developed to overcome this
Figure 3 Histograms showing the distributions of Fij, the frequency of each variant j within each individual sample i. Data were grouped as 
a function of m, the maximal number of variants for the gene within a sample: (A) for m = 2, (B) for m = 4 and (C) for m = 8. Histograms on the right 
display the distributions for values below ten percent: (D) for m = 2, (E) for m = 4 and (F) for m = 8.
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technical constraint e.g. [20,21,49]. However, in addition
to a poor resolution (variants within groups cannot be
distinguished), PCR-SSP requires a priori knowledge of
all the variant forms present in the population under
study. As oligonucleotide chips, it is thus not suitable for
most studies on non-model organisms. In our study, only
36 of 392 variants reported were already deposited in
GenBank. Based on these observations, the reproducibil-
ity of our genotyping (estimated at 95%) was very satisfac-
tory. The reproducibility of the classical methods
d e s cri bed  a bo v e  is  u n l i k e l y  t o  ev e r  a p p r oa c h  t h i s  h i g h
value. Moreover, at least a part, if not all, of our failed
results could be due to the low specificity of our primers
for some variants, rather than to our genotyping method.
Another disadvantage of using these indirect methods for
variant characterization is the difficulties encountered to
compare datasets generated in different laboratories, or
in the same laboratory but at different times. Such com-
parisons require complementary techniques to relate the
migration patterns, obtained using different machines or
laboratories, to a given allelic form. Such limitations inev-
itably preclude meta-analyses. Lastly, indirect methods
additionally require many PCR products to be sequenced
in order to link the sequence to a particular migration
pattern and thus to establish the migration patterns asso-
ciated with particular allelic forms. In cases involving dif-
ferent allelic forms in the same individual, or in cases
where the genes are duplicated or when selection favours
heterozygotes [50], further manipulations are often
needed before sequencing, such as gel excision or clon-
ing. These additional manipulations are time-consuming
and costly.
The 454 system overcomes most of these limitations by
making the variant sequences directly available during
genotyping. Furthermore, the variant does not need to be
isolated before sequencing. Indeed, the 454 methodology
includes emPCR, which separates the different DNA
strains during the first processing steps. Consequently,
the datasets can be studied without limitations concern-
ing the number of variants to be detected and without
any prior knowledge of the allelic forms present. Datasets
from different laboratories may then be easily concate-
nated for the purpose of meta-analyses. This approach is
suitable for genotyping individuals harboring high num-
bers of allelic forms. Other methods based on 454 system
have been developed previously and show some similari-
ties with ours. Babik et al. [31] carried out a 454 run to
genotype 96 rodents Myodes glareolus at exon 2 of the
DRB gene. They used 96 different tags and carried out 96
different purifications (i.e. as many tags and purifications
Table 3: Genetic variation in exon 2 sequences of the DRB gene observed for 1,407 rodent samples from 24 species and 11 
genera.
Rodent 
Genera
Number of DRB
copy amplified
Number of 
analysed samples
Replicates Genotyped 
(p = 0.999)
Heterozygotes 
genotyped
Number 
of variant
Mean number 
of sequences 
per variant
Nb % Nb % Nb %
Pool A
Myodes 2 650 33 5.1 602 93 495 82.2 71 834
Arvicola 1 49 2 4.1 49 100 36 73.5 13 324
Microtus 1 40 2 5.0 36 90 29 80.6 7 403
Apodemus 1 44 3 6.8 42 95 39 92.9 50 70
Pool B
Rattus 1 417 19 4.6 388 93 248 63.9 110 233
Mus 1 147 8 5.4 134 91 110 82.1 53 171
Niviventer 1 78 5 6.4 44 56 9 20.5 15 172
Bandicota 1 58 4 6.9 51 88 39 76.5 21 154
Berylmys 1 37 4 10.8 36 97 25 69.4 19 122
Leopoldamys 1 24 1 4.2 21 88 14 66.7 12 121
Maxomys 4 22 2 9.1 4 18 4 100.0 21 37
Total 1,566 83 5.3 1,407 90 1,048 74.5 392 277
The confidence level used for validating genotypes was fixed at 10-3.Galan et al. BMC Genomics 2010, 11:296
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as samples). By comparison, our method requires only a
single purification step after DNA pooling, and a far
smaller number of tags than samples for barcoding.
Moreover we did not need to perform a library to ligate
the adaptator prior to the emPCR. This reduces the num-
ber of steps (and so potential errors) during the labora-
tory experiment, and also greatly reduces the total cost of
the experiment (probably of a third).
Variants and genotype validation
In contrast to previous studies, our data processing relied
on a probabilistic model to establish clear and objective
thresholds for sequence and genotype validation. Other
studies have described alternative criteria. Babik et al.
[31] validated variants on the basis of their frequency
w i t h i n  i n d i v i d u a l s .  T h e y  c o n s i d e r e d  v a r i a n t s  w i t h  a n
observed frequency lower than 3% as artifacts, and thus
removed them from the dataset. Variants were also vali-
dated based on their dissimilarity with the four most
commonly found variant in a given sample. The valida-
tion score decreased when the similarity increased. This
filter did not include the detection of chimeras, since chi-
meras are very dissimilar from both parent variants and
may occur at a non-negligible frequency within individu-
als. In our study, we found chimeras to occur at a mean
frequency of 6%. Such limitations in the variant valida-
tion procedure could partly explain the high number of
variants per individual reported for Myodes glareolus in
the previous study (up to 18 different variants validated in
a single individual). Using our data validation procedure,
chimeras are discarded in the last step involving sequence
alignment and blast analyses. Another validation crite-
rion used by Babik et al. [31] was the need for a sequence
to occur in at least two different samples. This criterion
could lead to the removal of many variants that are rare in
populations. Such a bias may lead to misinterpretation of
the principal mode of selection operating on the gene
under study, or of the demographic tendencies of the
population under study. Indeed, rare variants may be
indicative of certain types of selection or demographic
events. For example, population expansion, purifying
selection or selective sweeps may result in an excess of
rare variants [51,52]. Our variant validation procedure
overcomes the problem of discarding rare variants
because it analyzes each sample separately. Our proce-
dure should also provide reliable results in cases where a
given variant may be an artifact in one sample but a true
variant in another sample. Another improvement of our
validation process is that we describe a statistically based
approach for determining a threshold (number of
sequences per sample) for validating genotypes. The
value of this threshold T2 may be redefined according to
the number of copies of the amplified gene and to the
ploidy level of the species studied. Our findings clearly
illustrate this point. Indeed, the number of sequences per
sample was sufficient for genotyping most of our rodents
with the exception of Maxomys  that displays multiple
copies of the gene. Finally we recommend the systematic
use of replicates for each 454 run, allowing the reproduc-
ibility of the genotyping procedure and, thus, the reliabil-
ity of the run, to be estimated.
Optimizing tagging and sample numbers
Our barcoding method led to 69% of the reads obtained
being assigned to samples. This proportion is lower than
the >95% reported by Binladen et al. [33] and Meyer et al.
[32], who used alternative barcoding methods. The effi-
ciency of our method could probably be improved by
using a Titanium kit (Roche Diagnostics GmbH) that pro-
vide longer reads. We estimated that 9% of the reads that
were unassigned were too short and did not encompass
the full length of the sequence for exon 2 of the DRB
gene. An estimated 8% of unassigned reads were attrib-
uted to the use of tags that form homopolymers GG with
the key sequence (i.e. 2 of 24 reverse tag sequences could
not be recovered as described above). It should thus be of
utmost importance to exclude such tags from the experi-
ment. Additionally, our criteria for the validation of reads
in the first step of data processing ma y ha ve been too
stringent. The search for perfect matches with the com-
plete primer sequences probably led to the elimination of
a large number of reads. This criterion was established to
discard reads that could present subsequent shifts in the
reading frame of the tag (Table 2). Alternatively, a perfect
match with only 5 to 10 bp of 5' sequences of the primers
may have been sufficient to discard reads associated with
reading frame shifts, and may have therefore allowed
more reads to be assigned to samples. Finally, it may be
possible to reduce the probability of incorrectly assigning
reads to a sample due to sequencing errors within the
tags. It is widely advised to use tags that differ by more
than one substitution [53]. However, this reduces the
number of combinations and thus the number of samples
that can be multiplexed. Increasing the number of nucle-
otides within tags could counterbalance this limitation.
The probabilistic model that we developed may be used
for optimizing the 454 run. When designing a 454 run, it
is important to take into account the fact that intcreasing
the number of samples results in fewer reads being
retrieved for each of them. The optimal number of sam-
ples to be multiplexed for genotyping with a given level of
confidence can be determined by simulating data before
the run. The number of copies in the genome for the gene
of interest must first be fixed, as well as the confidence
level required. The model will then generate the number
of sequences required per sample to give this confidence
level. The number of reads guaranteed by the provider
divided by the number of sequences generated by theGalan et al. BMC Genomics 2010, 11:296
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model will then give the optimal number of samples to be
multiplexed.
Conclusions
We have described a method for barcoding and multi-
plexing hundreds of PCR-amplicons using half of a 454
plate. We were able to reassign about 69% of the reads
generated to their sample of origin. The high number of
reads obtained for each sample then allowed the geno-
t y p e  o f  e a c h  s a m p l e  t o  b e  g e n e r a t e d .  W e  t h e n  u s e d  a
probabilistic model allowing variant validation and attri-
bution of a confidence level for each genotype based on
several objective criteria. Using this approach, we
obtained genotypes for exon 2 of the DRB gene in 1,407
samples from 1,374 rodents, belonging to 24 species. The
DRB gene is a highly variable coding gene that may be
duplicated several times in mammalian genomes.
This method may be improved in several ways. First,
using longer tags may increase the proportion of reads
that are finally assigned to their sample of origin, increase
the number of samples multiplexed and decrease the risk
of misassignment. Second, the number and order of the
different filters (i.e. Steps 1 to 4 of our processing) may be
modified and threshold values (T1 and T2) adapted to spe-
cific studies and genes. Here we applied three different
filters that are very different by nature. The first filter
(during Step 1) is related to the occurrence of variants
within the whole dataset. It consists in withdrawing all
the variants occurring only once in the dataset, which
considering our criteria would not have been validated at
the end of the process in any case. The second filter (dur-
ing Step 2, T1) is related to the number of sequences
yielded for each sample. It allows the elimination of sam-
ples (not variants) displaying too few sequences to be reli-
ably genotyped according to our probabilistic model. The
third filter (during Step 3, T2) is related to the number of
sequences obtained for each variant within each sample.
It consists in withdrawing variants that are present in low
frequency within the samples. It should be noted that we
decided to withdraw all variants occurring only once in
the data set at the very beginning of our processing
mainly for practical reasons. This considerably reduced
the size of the dataset (13,671 variants could be with-
drawn over a total of 19,847, i.e. a reduction of 69% in size
of the data set) and greatly facilitated further manipula-
tions. Yet this filter may be unnecessary because unique
sequences will be in any case removed during Step 3.
Besides we found logical to remove samples with too low
numbers of sequences (that would not have been consid-
ered in the final set of genotypes in any case) before try-
ing to discriminate true from artifactual variants within
samples. This was done because our main objective was
to get as many reliable genotypes as possible. This filter
may not be optimal for other purposes, like acquiring as
many variants (not genotypes) as possible for phyloge-
netic analyses, for instance. Lastly, the probabilistic
model that we developed may allow the number of sam-
ples multiplexed in one 454 run to be optimized, as a
function of the confidence level required for each geno-
type. The probabilistic approach proposed here may be
improved in order to take into account biases in PCR-
errors and yields. Our probabilities strongly depend on
restrictive hypotheses (considering that all events have
the same probability to occur whatever the nucleotide
changes and sites considered). In this respect, our
approach may provide null expectations for PCR-bias
testing. Non-random processes in PCR-errors and yields
like unequal probabilities of nucleotide changes, PCR-
competition among variants and errors hotspots may (at
least in theory) induce significant departures from our
predictions. In our paper we provide a rough estimate of
the probability of substitution errors based on our data
(see Additional Information [Additional file 1]). More
accurate estimates may result from inclusion of internal
controls (i.e. variants of known sequences), which should
be systematically incorporated in future experiments.
Moreover, because most PCR-biases are expected to
depend on data (i.e. organisms, genes, variants ...) as well
as experiments (i.e. chemicals, laboratories ...), we think
that more realistic models should further be based on the
use of internal controls for model selection and parame-
ter estimation. In the meanwhile we recommend com-
pensating for such potential biases by choosing a high
theoretical level of reliability for genotyping (99.9%)
within our neutral model. Finally, an automated bioinfor-
matics pipeline based on our stepwise procedure is cur-
rently being developed and will be available to other
projects that may benefit from this genotyping approach.
We believe that this methodology will be very useful for
evolutionary and functional studies in the near future.
Additional material
Additional file 1 Additional Information. Probabilities of observing arti-
factual sequences by substitution errors. Probability f(r,m,n) of observing at 
least r sequences of each of the m variants potentially observed for the n 
sequences of a given sample.
Additional file 2 Fig S1, Fig S2, Fig S3, Fig S6. Figure S1. Histograms 
showing the number of sequences obtained for individual variants (Nj) for 
pools A and B. Insets display distributions for values below fifty. Figure S2. 
Histograms of the number of sequences obtained for each sample (Ni) after 
the first step of data processing for pools A and B. Figure S3. Confidence 
level for genotyping. f is the probability of amplifying, at least r times, all the 
different variants of the gene studied for a given sample. This probability 
depends on n, the total number of sequences by sample, and m, the maxi-
mal number of variants for the gene within a sample. T1 is the threshold 
value that corresponds to the minimal number of sequences required per 
individual to determine its complete genotype, with a 10-3 probability of 
missing variants. Plots are given for different values of r = 1, 2, 5 and 10. Fig-
ure S6. The number of sequences obtained for each forward and reverse 
tag after the first step of data processing for pools A and B.Galan et al. BMC Genomics 2010, 11:296
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